Latest Stories
Shyft (NASDAQ:SHYF) Misses Q4 Sales Targets
Vehicle manufacturer Shyft (NASDAQ:SHYF) fell short of the market’s revenue expectations in Q4 CY2024, with sales flat year on year at $201.4 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $920 million at the midpoint. Its non-GAAP profit of $0.15 per share was 18.4% above analysts’ consensus estimates.
Leonardo DRS (NASDAQ:DRS) Posts Better-Than-Expected Sales In Q4, Full-Year Sales Guidance is Optimistic
Aerospace and defense company Leonardo DRS (NASDAQ:DRS) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 5.9% year on year to $981 million. The company’s full-year revenue guidance of $3.48 billion at the midpoint came in 1.6% above analysts’ estimates. Its non-GAAP profit of $0.38 per share was 7.6% above analysts’ consensus estimates.
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $167.5 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $697.5 million at the midpoint. Its non-GAAP profit of $0.44 per share was 7.9% above analysts’ consensus estimates.